Market Closed -
Nasdaq
20:59:22 18/06/2025 BST
5-day change
1st Jan Change
145.67 USD
+0.50%
-1.93%
+61.55%
IRhythm Technologies Plans to Offer $450 in Convertible Notes Due 2029
Published on 04/03/2024 at 14:14,
updated on 04/03/2024 at 14:15
IRhythm Technologies, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 02:40 PM
06-10
Morgan Stanley Raises iRhythm Technologies Price Target to $160 From $130, Maintains Overweight Rating
06-10
MT
IRhythm Technologies, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 03:40 PM
05-23
IRhythm Technologies Shares Jump After Q1 Revenue Beat
05-02
MT
Wells Fargo Upgrades iRhythm Technologies to Overweight, Price Target is $130
05-02
MT
IRhythm Technologies Q1 Adjusted Loss Narrows, Revenue Rises; 2025 Sales Guidance Raised
05-02
MT
IRhythm Technologies, Inc., Q1 2025 Earnings Call, May 01, 2025
05-01
Earnings Flash (IRTC) IRHYTHM Posts Q1 Loss $-0.95 Per Share, vs. FactSet Est of $-0.94
05-01
MT
Earnings Flash (IRTC) IRHYTHM Posts Q1 Revenue $158.7M, vs. FactSet Est of $153.4M
05-01
MT
IRhythm Technologies, Inc. Launches Zio Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection
05-01
CI
IRhythm Technologies, Inc. Provides Revenue Guidance for the Full Year 2025
05-01
CI
IRhythm Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025
05-01
CI
IRhythm Technologies Says Zio LTCM Shows 'Highest Diagnostic Yield' Vs Other Devices
04-28
MT
IRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring
04-28
CI
Truist Cuts Price Target on iRhythm Technologies to $120 From $145, Keeps Buy Rating
04-11
MT
Trump Tariffs Will Sow Long-term Structural Dislocation, Oppenheimer Says
04-07
MT
IRhythm Technologies, Inc. Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio Long-Term Continuous Monitoring for Arrhythmia Detection
03-31
CI
Trump turbulence stalls large pharma and biotech deals, bankers say
03-26
RE
Irhythm Technologies Insider Sold Shares Worth $299,770, According to a Recent SEC Filing
03-04
MT
Irhythm Technologies Insider Sold Shares Worth $334,468, According to a Recent SEC Filing
03-04
MT
Irhythm Technologies Insider Sold Shares Worth $1,538,218, According to a Recent SEC Filing
02-27
MT
Irhythm Technologies Insider Sold Shares Worth $281,671, According to a Recent SEC Filing
02-27
MT
Irhythm Technologies Insider Sold Shares Worth $2,495,117, According to a Recent SEC Filing
02-27
MT
Irhythm Technologies Insider Sold Shares Worth $1,791,041, According to a Recent SEC Filing
02-27
MT
Truist Adjusts iRhythm Technologies' Price Target to $145 From $111, Keeps Buy Rating
02-21
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
IRTC: Dynamic Chart
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
More about the company
Last Close Price
145.53 USD
Average target price
143.83 USD
Spread / Average Target
-1.17%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
Select your edition
All financial news and data tailored to specific country editions